ALLR Allarity Therapeutics, Inc. - Common stock
$1,53
Precio · May 20, 2026
Fundamentales a fecha de May 15, 2026
Rango 52S
$1–$2
47% of range
Calificación del Analista
BUY
7 analysts
Precio Objetivo
$10
+539% upside
P/E (TTM)
-0.0
ROE
-102.1%
Margen de Beneficio Neto
-3509.7%
ALLR Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$1.52
Capitalización Bursátil
$17M
P/E (TTM)
-0.0
BPA (TTM)
$-10.26
Ingresos (TTM)
$320.0K
Rendimiento div.
—
ROE
-102.1%
Deuda/Capital
—
Rango 52S
$1 – $2
ALLR Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$320.0K
2024-12-31
→
2025-12-31
BPA
$-10.26
2021-12-31
→
2023-12-31
Flujo de caja libre
$-15M
2022-12-31
→
2025-12-31
Márgenes
-3509.7%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
ALLR
Mediana de Pares
P/E (TTM)
-0.0
—
P/S (TTM) (P/V (TTM))
54.3
14.0
P/B (P/C)
1.8
2.0
Price / FCF (Precio / FCF)
-1.2
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
ALLR
Mediana de Pares
Operating Margin (Margen Operativo)
-3939.1%
—
Net Profit Margin (Margen de Beneficio Neto)
-3509.7%
-3396.1%
ROA
-54.9%
-68.9%
ROE
-102.1%
-110.3%
ROIC
-128.3%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
ALLR
Mediana de Pares
Current Ratio (Ratio corriente)
2.1
1.4
Quick Ratio (Ratio Rápido)
1.7
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
ALLR
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
ALLR
Mediana de Pares
ALLR Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
7 analistas
- Compra fuerte 2 28,6%
- Compra 4 57,1%
- Mantener 1 14,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
1 analistas · 2026-05-19
Mín
$9.75
Máx
$9.75
Objetivo mediano
$9.75
+539,3%
Objetivo medio
$9.75
+539,3%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
1.1%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.17 | $-0.22 | 0.05% |
| 31 de diciembre de 2025 | $-0.21 | $-0.22 | 0.01% |
| 30 de septiembre de 2025 | $-0.19 | $-0.23 | 0.04% |
| 30 de junio de 2025 | $-0.15 | $-0.21 | 0.06% |
| 30 de septiembre de 2024 | $-7.71 | $-8.69 | 0.98% |
| 30 de junio de 2024 | $-3.30 | $-8.78 | 5.5% |
Comparación con pares Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| ALLR | $17M | -0.0 | — | -3509.7% | -102.1% | — |
| KTTA | — | — | — | — | — | — |
| SNSE | $13M | -0.6 | — | — | -91.9% | — |
| GRDX | $20M | -1.1 | — | -17634.4% | -68.6% | -1813.6% |
| CELU | $32M | -0.3 | -51.0% | -345.4% | 288.6% | — |
| MRKR | $25M | -1.9 | -46.2% | -343.0% | -89.1% | — |
| HOWL | $31M | -0.5 | — | — | -183.6% | — |
| CRIS | $13M | -1.7 | -13.4% | -80.3% | 177.9% | — |
| XCUR | $35M | -6.9 | — | — | -77.3% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 13
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue | $320.0K | $0 | |
| R&D Expense | $7M | $6M | |
| SG&A Expense | $6M | $11M | |
| Operating Expenses | $13M | $27M | |
| Operating Income | $-13M | $-27M | |
| Interest Income | $801.0K | $533.0K | |
| Other Non-op | $1M | $2M | |
| Pretax Income | $-11M | $-25M | |
| Income Tax | $0 | $-381.0K | |
| Net Income | $-11M | $-25M | |
| EPS (Basic) | $-0.78 | $-15.65 | |
| Shares (Basic) | 14,378,942 | 1,606,989 | |
| EBITDA | $-13M | $-27M |
Balance general 21
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $15M | $20M | |
| Prepaid Expense | $2M | $507.0K | |
| Other Current Assets | $265.0K | $115.0K | |
| Current Assets | $18M | $22M | |
| PP&E (Net) | $330.0K | $309.0K | |
| Intangibles | · | $0 | |
| Total Assets | $18M | $23M | |
| Accounts Payable | $4M | $4M | |
| Accrued Liabilities | $3M | $5M | |
| Short-term Debt | $0 | · | |
| Current Liabilities | $8M | $11M | |
| Deferred Tax | · | $0 | |
| Total Liabilities | $8M | $11M | |
| Common Stock | $3.0K | $1.0K | |
| Paid-in Capital | $144M | $131M | |
| Retained Earnings | $-130M | $-119M | |
| Treasury Stock | $3M | $0 | |
| AOCI | $-1M | $-354.0K | |
| Stockholders' Equity | $10M | $12M | |
| Liabilities + Equity | $18M | $23M | |
| Shares Outstanding | 16,080,980 | 7,302,797 |
Flujo de Efectivo 13
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| D&A | · | $9.0K | |
| Stock-based Comp | $482.0K | $71.0K | |
| Deferred Tax | $0 | $-381.0K | |
| Other Non-cash | · | $7M | |
| Operating Cash Flow | $-15M | $-17M | |
| CapEx | $8.0K | $298.0K | |
| Investing Cash Flow | $-8.0K | $-298.0K | |
| Stock Issued | $11M | $37M | |
| Stock Repurchased | $3M | $0 | |
| Net Stock Activity | $8M | $37M | |
| Financing Cash Flow | $11M | $37M | |
| Taxes Paid | · | $0 | |
| Free Cash Flow | $-15M | $-18M |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -3939.1% | · | |
| Net Margin | -3509.7% | · | |
| Pretax Margin | -3509.7% | · | |
| EBITDA Margin | -3939.1% | · | |
| ROA | -54.9% | -142.1% | |
| ROE | -102.1% | -197.9% | |
| ROIC | -128.3% | -227.1% |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 2.1 | 2.1 | |
| Quick Ratio | 1.7 | 1.8 |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.0 | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $320.0K | $0 | |
| Net Income TTM | $-11M | $-25M | |
| Market Cap | $17M | $9M | |
| P/E | -0.0 | -0.0 | |
| P/S | 54.3 | · | |
| P/B | 1.8 | 0.7 | |
| P / Tangible Book | 1.8 | 0.7 | |
| P / Cash Flow | -1.2 | -0.5 | |
| P / FCF | -1.2 | -0.5 | |
| Earnings Yield | -50908.3% | -46992.3% |
Estado de resultados 13
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $25.0K | · | · | · | $0 | |
| R&D Expense | $1M | $2M | $1M | $2M | $1M | |
| SG&A Expense | $1M | $2M | $1M | $2M | $2M | |
| Operating Expenses | $3M | $3M | $3M | $4M | $3M | |
| Operating Income | $-3M | $-3M | $-3M | $-4M | $-3M | |
| Interest Income | $163.0K | $155.0K | $187.0K | $237.0K | $222.0K | |
| Other Non-op | $-62.0K | $-455.0K | $-288.0K | $2M | $304.0K | |
| Pretax Income | · | $-3M | $-3M | $-2M | $-3M | |
| Income Tax | · | $0 | $0 | $0 | $0 | |
| Net Income | $-3M | $-3M | $-3M | $-2M | $-3M | |
| EPS (Basic) | $-0.17 | $-0.19 | $-0.19 | $-0.15 | $-0.25 | |
| Shares (Basic) | 15,968,591 | -27,051,101 | 14,739,800 | 15,543,321 | 11,146,922 | |
| EBITDA | $-3M | · | $-3M | $-4M | $-3M |
Balance general 20
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $15M | $17M | $18M | $25M | |
| Prepaid Expense | $4M | $2M | $2M | $1M | $493.0K | |
| Other Current Assets | $108.0K | $265.0K | $113.0K | $116.0K | $110.0K | |
| Current Assets | $35M | $18M | $20M | $21M | $29M | |
| PP&E (Net) | $420.0K | $330.0K | $330.0K | $322.0K | $308.0K | |
| Total Assets | $35M | $18M | $21M | $21M | $30M | |
| Accounts Payable | $4M | $4M | $5M | $5M | $4M | |
| Accrued Liabilities | $2M | $3M | $3M | $3M | $5M | |
| Short-term Debt | $20M | · | · | · | · | |
| Current Liabilities | $28M | $8M | $9M | $9M | $11M | |
| Total Liabilities | $28M | $8M | $9M | $9M | $11M | |
| Total Debt | $20M | · | · | · | · | |
| Common Stock | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | |
| Paid-in Capital | $144M | $144M | $144M | $141M | $141M | |
| Retained Earnings | $-133M | $-130M | $-127M | $-124M | $-122M | |
| Treasury Stock | $3M | $3M | $3M | $3M | · | |
| AOCI | $-1M | $-1M | $-2M | $-2M | $-630.0K | |
| Stockholders' Equity | $7M | $10M | $12M | $12M | $19M | |
| Liabilities + Equity | $35M | $18M | $21M | $21M | $30M | |
| Shares Outstanding | 15,818,980 | 16,080,980 | 16,111,461 | 14,619,636 | 17,021,970 |
Flujo de Efectivo 11
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| D&A | · | · | · | $12.0K | $11.0K | |
| Stock-based Comp | $160.0K | $47.0K | $132.0K | $164.0K | $139.0K | |
| Other Non-cash | · | · | · | · | $-104.0K | |
| Operating Cash Flow | $-4M | $-3M | $-3M | $-5M | $-3M | |
| CapEx | $64.0K | · | · | · | $0 | |
| Investing Cash Flow | $-64.0K | · | · | · | $0 | |
| Stock Issued | $0 | $0 | $0 | $0 | $11M | |
| Stock Repurchased | $262.0K | $484.0K | $141.0K | $3M | $0 | |
| Net Stock Activity | $-262.0K | · | · | · | $11M | |
| Financing Cash Flow | $20M | $-240.0K | $2M | $-3M | $11M | |
| Free Cash Flow | $-5M | · | · | · | · |
Rentabilidad 6
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Operating Margin | -10752.0% | · | · | · | · | |
| Net Margin | -11000.0% | · | · | · | · | |
| EBITDA Margin | -10752.0% | · | · | · | · | |
| ROA | -8.5% | · | -13.6% | -8.9% | -13.1% | |
| ROE | -21.5% | · | -22.5% | -14.5% | -44.8% | |
| ROIC | · | · | -21.0% | -34.0% | -16.3% |
Liquidez y Solvencia 3
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | · | 2.3 | 2.3 | 2.7 | |
| Quick Ratio | 0.7 | · | 1.9 | 2.0 | 2.3 | |
| Debt / Equity | 2.9 | · | · | · | · |
Eficiencia 1
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · |
Valoración (TTM) 11
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-11M | · | $-19M | $-18M | $-20M | |
| Market Cap | $17M | · | $25M | $15M | $16M | |
| Enterprise Value | $18M | · | · | · | · | |
| P/E | -0.0 | · | -0.0 | -0.0 | -0.0 | |
| P/B | 2.5 | · | 2.1 | 1.2 | 0.9 | |
| P / Tangible Book | 2.5 | · | 2.1 | 1.2 | 0.9 | |
| P / Cash Flow | -3.8 | · | · | · | -5.9 | |
| P / FCF | -3.8 | · | · | · | · | |
| EV / EBITDA | -6.5 | · | · | · | · | |
| EV / FCF | -3.8 | · | · | · | · | |
| Earnings Yield | -50441.3% | · | -34798.1% | -54436.6% | -58677.7% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $320.0K | $0 | — | — | — |
| Margen Operativo % | -3939.1% | — | — | — | 1971.5% |
| Beneficio neto | $-11M | $-25M | $-12M | $-16M | $-27M |
| EPS Diluido | — | — | $-10.26 | $-3093.42 | $-4.19 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 2.1 | 2.1 | — | 0.4 | 1.0 |
| Ratio Rápido | 1.7 | 1.8 | — | 0.2 | 0.9 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-15M | $-18M | — | $-17M | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.